The Growth Channel

The latest innovations in market strategy and share competition

Tired of "no-show" patients? Use predictive overbooking.

by Gunjan Desai January 10, 2017

Patient absenteeism for scheduled visits and procedures occurs frequently in clinics, resulting in treatment delays, unnecessarily long wait times, and inefficient use of clinic resources.

Predictive overbooking helps clinics improve access for current and potential patients, while also ensuring clinic resources are used efficiently. Predictive overbooking uses electronic health record data to identify scheduled "no-shows," or patients who are at a high risk for missing procedures. Then, the program double-books these appointments with the no-show patient and a patient more likely to show up.

Read more »

How will health policy changes affect oncology?

by Julia Venanzi December 15, 2016

After the recent election, you may be wondering how health care policy reform will affect your cancer program's strategy moving forward.

This and other pressing topics will be addressed at the upcoming Cancer Center Business Summit on Feb. 6 - 7. A panel of provider and industry experts will discuss exactly what policies like MACRA mean for the day-to-day experiences of cancer patients, providers, and insurers amid the increased uncertainty under the new administration.

Read more »

3 ways to make capital investments without breaking the bank

by Carrie Wolf December 13, 2016

We get a lot of questions from organizations looking to drive growth by investing in new technologies and service offerings. Such efforts typically also come with a hefty price tag.

Here are three strategies we've seen service line leaders and planners pursue to grow their programs while working around a tight budget:

Read more »

Congress passed the ECHO Act—what does this mean for telehealth?

by Cara Goerlich December 7, 2016

On Tuesday, the House approved the ECHO Act by voice vote, following the Senate's unanimous vote in favor of the bill on Nov. 29. If the president signs the bill into law, the ECHO Act would expand the University of New Mexico's Project ECHO as a national model. This legislation signals telehealth's broad appeal as a uniquely bipartisan solution in an increasingly divided policy landscape. But does this mean telehealth has finally reached its "tipping point?" Our experts weigh in:

Read more »

From A to Z: The growth curve for children's health systems

Alan Lassiter MD, MBA December 6, 2016

When I started my career in pediatric medicine 25 years ago, I could not have imagined how many changes—and challenges—would unfold in the world of pediatric health care. Today's systems are faced with a smorgasbord of mission-critical questions, including:

  • How do we evolve from a hospital-centric to a patient-centric system?
  • What do partnerships look like in the new world?
  • What is our retail strategy?
  • How do we manage the Medicaid population under new models requiring us to assume risk?

Read more »

One way to bridge the gap between fee-for-service and population health

by Sebastian Beckmann November 16, 2016

It's an issue that many of the planners we talk to bring up all the time: how can we strategize both for growth and for population health?

As more systems transition toward value, planners need to meet priorities under both models. That means you have to grow volumes to feed your business, but you also need to find a way to control overall spending.

In the sports medicine world, we're starting to see one program that offers a solution: wellness centers.

Read more »

How good is your strategic plan?

by Kate Myers and Shay Pratt November 7, 2016

As we approach 2017, lots of people are putting pen to paper on their strategic plans. We sat down with our strategic planning expert, Shay Pratt, to talk about what we can learn from those who do it best.

Read more »

The new Medicare Part B drug payment model: What you need to know

by Catherine Schmalkuche November 3, 2016

As part of its ongoing effort to transition health care toward value-based care, the Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement model for drugs that fall under Medicare Part B. The new model is designed to restructure physician incentives when it comes to choosing which drugs to use. The end goal is to reduce expenditures while maintaining or even improving patient outcomes; however, the approach is likely to pose significant financial challenges for providers, especially for cancer programs and smaller practices.

Here is a short breakdown of how the proposed rule works, as well as three key takeaways planners need to know about.

Read more »

  • Manage your events
  • View your saved items
  • Manage your subscriptions
  • Update personal information
  • Invite a colleague